Johnson and Johnson to acquire Abiomed for USD 16.6 billion to boost cardiovascular business Ruchika Sharma2 Nov 2022 12:30 PM ISTNew Brunswick: Johnson & Johnson and Abiomed have entered into a definitive agreement under which Johnson & Johnson will acquire through a...
Janssen TECVAYLI gets USFDA nod for relapsed or refractory multiple myeloma Ruchika Sharma29 Oct 2022 10:00 AM ISTTECVAYLI is a first-in-class, bispecific T-cell engager antibody that is administered as a subcutaneous treatment.
JnJ sells Telangana plant to Hetero for Rs 130 crore Ruchika Sharma18 Oct 2022 1:30 PM ISTThe facility will be Hetero's flagship sterile pharmaceutical and biologics manufacturing unit and will generate 2,000 new jobs, Hetero said in a...
Former JnJ executive Mathai Mammen emerges as top candidate to head Biogen as CEO: Report Ruchika Sharma8 Oct 2022 12:15 PM ISTVounatsos is serving as CEO until a successor is appointed.
Janssen bags USFDA nod for IMBRUVICA for chronic graft-versus-host disease treatment Ruchika Sharma28 Aug 2022 12:45 PM ISTChronic graft-versus-host disease is a life-threatening complication that can occur after a stem cell or bone marrow transplant when newly...
JnJ to stop manufacturing its talc based baby powder from 2023 Roshni Dhar13 Aug 2022 5:51 PM ISTJohnson & Johnson will stop selling talc-based baby powder globally in 2023, the drug maker said on Thursday, more than two years after it ended...
Health Bulletin 13/August/2022 Roshni Dhar13 Aug 2022 5:20 PM ISTHere are the top health stories for the day:With strict bond terms, Rajasthan in-service PG medicos facing trouble getting study leaveWith the State...
Mired in controversy, JNJ baby powder to go off shelves from 2023 Ruchika Sharma13 Aug 2022 2:00 PM ISTThe company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with...
Mathai Mammen leaves position as JnJ Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma12 Aug 2022 3:00 PM ISTNew Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice...
Johnson and Johnson cancer drug sales help weather hit from stronger dollar Ruchika Sharma20 July 2022 2:00 PM ISTThe company said it was raising prices of some products like painkillers and mouthwash in response to inflation.
Janssen Pharma gets USFDA Breakthrough Therapy Designation for Multiple Myeloma treatment Talquetamab Ruchika Sharma30 Jun 2022 3:02 PM ISTTalquetamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting both GPRC5D, a novel drug target, on multiple...
WHO gives nod to Biological E as additional production site for JnJ COVID vaccine Ruchika Sharma23 Jun 2022 4:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age...
